Commercializing Stem Cell-Based Therapies: Meeting NIH and FDA Requirements by Kalah Auchincloss

Published date09 September 2009
Law FirmFoley Hoag LLP
Subject MatterBarack Obama,FDA,Human Embryos,NIH,Stem cells

To continue reading

Request your trial

VLEX uses login cookies to provide you with a better browsing experience. If you click on 'Accept' or continue browsing this site we consider that you accept our cookie policy. ACCEPT